Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
CITIC Securities | This Week's Selected In-Depth Research Reports
Log in to Sina Finance App and search for [Information Disclosure] to see more evaluation levels.
We believe that as the Chinese medicine industry shifts from quantity to quality, traditional Chinese medicine companies will face development challenges. Future industry growth will occur alongside adjustments. Looking ahead to 2026, short-term pressure from base effects is expected to gradually ease, with a focus on improving industry fundamentals; in the long term, attention should be paid to policies like the essential drug list and progress in industry transformation and upgrading. Overall, the industry is bottoming out and recovering; it is recommended to focus on leading companies with stable operations.
Report Source
Securities Research Report Title: “Review of Five Bull Markets in A-shares and Hong Kong Stocks — New Framework for Asset Allocation (13)”
Publication Date: March 13, 2026
Published by: CITIC Securities Co., Ltd.
Analysts:
Zhou Junzhi SAC No.: S1440524020001
Mao Chen SAC No.: S1440523030002
Securities Research Report Title: “State-Owned Enterprise Venture Capital Fund Operations and Industry-Finance Collaboration — Series Five of SOE Reform”
Publication Date: March 13, 2026
Published by: CITIC Securities Co., Ltd.
Analysts:
Zhang Yulong SAC No.: S1440518070002
SFC No.: BPW299
Wang Dalin SAC No.: S1440520110002
Securities Research Report Title: “Review and Outlook of the Chinese Medicine Industry: From Quantity to Quality, Growth and Adjustment in Parallel”
Publication Date: March 15, 2026
Published by: CITIC Securities Co., Ltd.
Analysts:
Yuan Qinghui SAC No.: S1440520030001
SFC No.: BPW879
Liu Ruofei SAC No.: S1440519080003
SFC No.: BVX723
He Juying SAC No.: S1440517050001
SFC No.: ASZ591
Yuan Quan SAC No.: S1440523070006
Shen Xingxi SAC No.: S1440525070009
Securities Research Report Title: “Analyzing the Russia-Ukraine Impact: Adding Power Equipment and New Energy”
Publication Date: March 15, 2026
Published by: CITIC Securities Co., Ltd.
Analysts:
Zhu Yue SAC No.: S1440521100008
SFC No.: BTM546
Xu Lin SAC No.: S1440522110001
SFC No.: BVU271
Lei Yunze SAC No.: S1440523110002
Chen Sitong SAC No.: S1440522080006
Zheng Boyuan SAC No.: S1440524080004
Hu Ying SAC No.: S1440524050002
Wang Jiying SAC No.: S1440521120004
Securities Research Report Title: “Profitability Improvement Breaks the Deadlock, Valuation Bottoming and Starting a New Chapter — In-Depth Study of Lithium Iron Phosphate Cathode Industry”
Publication Date: March 16, 2026
Published by: CITIC Securities Co., Ltd.
Analysts:
Xu Lin SAC No.: S1440522110001
Zhu Yue SAC No.: S1440521100008
Securities Research Report Title: “Spring Breeze and Warm Currents, 6F/VC as the Best”
Publication Date: March 16, 2026
Published by: CITIC Securities Co., Ltd.
Analysts:
Xu Lin SAC No.: S1440522110001
Xue Lu SAC No.: S1440525090001
Securities Research Report Title: “North America Power Shortage Difficult to Reverse: Energy Storage and Grid Construction to Soon Replicate Gas Turbine Boom”
Publication Date: March 18, 2026
Published by: CITIC Securities Co., Ltd.
Analysts:
Zhu Yue SAC No.: S1440521100008
SFC No.: BTM546
Lei Yunze SAC No.: S1440523110002
Securities Research Report Title: “Outlets Industry Resilience Highlights, Favoring Leading Operators and REITs — Real Estate Asset Securitization Series (IV)”
Publication Date: March 19, 2026
Published by: CITIC Securities Co., Ltd.
Analysts:
Huang Xiaotian SAC No.: S1440520070013
Securities Research Report Title: “Cognitive Revolution: The Capability Ladder and Value Rebuilding of AI Investment Research (L1-L5)”
Publication Date: March 20, 2026
Published by: CITIC Securities Co., Ltd.
Analysts:
Yao Ziwei SAC No.: S1440524040001
Important Notice and Disclaimer
Important Notice:
The views and information published through this subscription account are for reference only by institutional professional investors who meet the requirements of the “Securities and Futures Investors Suitability Management Measures” and are clients of CITIC Securities Co., Ltd. (“CITIC Securities”). Since this subscription account currently cannot set access restrictions, if you are not an institutional professional investor among CITIC Securities’ clients, please cancel your follow to control investment risks and do not subscribe to, receive, or use any information from this account. We sincerely apologize for any inconvenience caused and thank you for your understanding and cooperation.
The content on this subscription account is only intended for institutional professional investors who meet the requirements of the “Securities and Futures Investors Suitability Management Measures.” CITIC Securities does not consider subscribers or recipients of this account’s content as clients of CITIC Securities solely by virtue of subscribing or receiving.
This account is not a platform for publishing CITIC Securities research reports. All content comes from officially published research reports or follow-up and interpretations of those reports. Subscribers may misunderstand key assumptions, ratings, target prices, etc., if they lack full report context. Please refer to the complete published research reports, carefully read all disclosures, information, and risk warnings, and pay attention to the key assumptions behind the analysis and forecasts, the timing of investment ratings and target prices, and understand the meaning of investment ratings accurately.
CITIC Securities makes no explicit or implicit guarantees regarding the accuracy, reliability, timeliness, or completeness of the information on this account. The opinions and information are only as of the date of the original research report and may be updated without notice based on subsequent reports. Sales, trading, and other professionals at CITIC Securities may issue market comments or opinions that differ from those on this account, based on different assumptions, standards, or analysis methods.
The content published on this account does not constitute investment advice and should not be construed as investment recommendations under any circumstances. Subscribers should understand the risks involved, make independent investment decisions based on their own circumstances, and bear all associated risks. Any decisions made based on this content are unrelated to CITIC Securities or the authors.
All content on this account is owned by CITIC Securities. No organization or individual may reproduce, copy, publish, or quote any part of this content without prior written permission from CITIC Securities, nor may they receive, reproduce, copy, or quote the content from any unauthorized media platform or organization. All rights reserved.